Lv3
400 积分 2025-03-06 加入
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
26天前
已完结
Annexin A5: shifting from a diagnostic towards a therapeutic realm
4个月前
已完结
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
4个月前
已完结
Nonalcoholic Steatohepatitis
4个月前
已完结
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
6个月前
已完结
The OGT–TFF2 axis mediates intrahepatic crosstalk and MASH pathogenesis
6个月前
已完结
A Review on the Potential Role of Humanin Peptide and its Analogs in the Regulation of Autophagy Pathways for Therapeutic Application in Metabolic Disorders
7个月前
已完结
SIRT7 regulates T-cell antitumor immunity through modulation BCAA and fatty acid metabolism
7个月前
已完结
A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance
7个月前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
7个月前
已完结
皖公网安备34019202002308
